Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that it has entered into definitive ...
The company was delisted from Nasdaq last year after noncompliance issues. Now it plans a sale process to maximize value for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results